Folinic Acid (Active Folate).

Folate hands its methyl group to cobalamin in methionine synthase, so the two work in one reaction. Without B12 the folate pool accumulates in its methyl form and cannot return to the other one-carbon steps.

Folinic acid is 5-formyltetrahydrofolate, which enters the reduced folate pool without needing dihydrofolate reductase and can be converted onward to the methyl form. The two cover different points of the same pool.

MTHFR, which produces methylfolate from the methylene form, is a flavoprotein requiring FAD. Riboflavin sets how well folinic acid can be carried through to the methyl form.

Serine hydroxymethyltransferase loads one-carbon units onto tetrahydrofolate using pyridoxal-5-phosphate. B6 fills the folate pool that folinic acid enters.

Serine is the principal donor of one-carbon units to tetrahydrofolate, producing glycine in the process. Folate carries the unit that serine supplies.

The glycine cleavage system transfers a one-carbon unit to tetrahydrofolate, and the serine and glycine interconversion runs on the same folate carrier. Glycine sits on both sides of that exchange.

Betaine remethylates homocysteine through BHMT without using folate, giving the methyl cycle a second lane. It reduces the draw on the folate-dependent route.

Choline is oxidised to betaine, the substrate of the folate-independent remethylation route, so choline and folate demand move against each other. Supplying both keeps either route from being the limit.

Glutamate carboxypeptidase II, the brush border enzyme that removes polyglutamate tails before folate uptake, is zinc-dependent. Zinc status therefore affects folate absorption directly.

SAM is the methyl donor produced downstream of the folate cycle and it also inhibits MTHFR as a feedback signal. The two sit on one regulated loop.

EGCG inhibits dihydrofolate reductase and intestinal folate transport in laboratory work. Large catechin doses taken with folate can therefore work against absorption and reduction.

Folate and B12 supply one-carbon units for DNA synthesis in dividing precursor cells while iron builds the haem. The three are combined because each limits the same process.

Folic acid is fully oxidised and needs dihydrofolate reductase twice to enter the active pool; folinic acid is already reduced and bypasses that enzyme. Both use the reduced folate carrier and the proton-coupled folate transporter to get into cells, so they compete at the door. Human dihydrofolate reductase capacity is low, which is why unmetabolised folic acid appears in plasma at higher intakes while folinic acid does not.

Folinic acid is supplied almost universally as calcium folinate, because the free acid is unstable and the calcium salt crystallises cleanly and keeps well. The calcium is a counter-ion, not an active partner, and it contributes a small amount to a formula's calcium total. This is formulation practice rather than a nutrient interaction.

Methionine is regenerated from homocysteine using a methyl group carried by 5-methyl-THF, the downstream product of the folinic acid pool. A high methionine load raises the homocysteine flux that folate has to handle. The two sit on opposite ends of the same cycle, so the relationship is directional rather than simply additive.

Histidine breakdown passes through formiminoglutamate, whose formimino group is transferred onto tetrahydrofolate. When folate is short, that intermediate accumulates, which is the basis of the classic histidine load test. Folinic acid feeds the tetrahydrofolate pool that accepts the transfer.

Reduced folates oxidise readily in solution and in the gut, and ascorbate holds them in the reduced state, which is why folate assays and food fortification work use it as a stabiliser. The practical effect on absorption from a supplement has not been isolated in human trials. Read it as chemistry with a plausible formulation consequence.

Several Bifidobacterium and Lactobacillus strains synthesise folate in the colon, and the review of folate and the gut microbiome describes both bacterial production and host absorption through the colonic transporter. Colonic folate contribution to status in people is not settled and varies by strain. This is a mechanism with review support, not a demonstrated effect on blood folate.

Fermentable fibres shift colonic populations toward bifidobacteria, some of which produce folate. Whether that translates into a measurable change in host folate status is unresolved in the human literature. The pairing is mechanistically coherent and the evidence is early.

Dihydrofolate reductase and methylenetetrahydrofolate reductase both run on NADPH, and niacin supplies the nicotinamide ring of that cofactor. Folinic acid is less dependent on the first of those enzymes than folic acid is, but the downstream methylation step still needs reducing equivalents. This is cofactor biochemistry, not a tested combination.